Carl Heneghan and colleagues describe how failings in the process for the marketing approval of implantable transvaginal mesh devices may have exposed women to avoidable harms and how to avoid their repetition
No takes yet. Share an insight, caveat, or question.
Heneghan et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: